Return to CG130 Overview

Hyperglycaemia in acute coronary syndromes: management of hyperglycaemia in acute coronary syndromes [CG130]

Measuring the use of this guidance

Recommendation: 1.1.1

Manage hyperglycaemia in patients admitted to hospital for an acute coronary syndrome (ACS) by keeping blood glucose levels below 11.0 mmol/litre while avoiding hypoglycaemia. In the first instance, consider a dose-adjusted insulin infusion with regular monitoring of blood glucose levels.

What was measured: Proportion of hyperglycaemic ACS patients commenced on an insulin infusion.
Data collection end: December 2012
17.3%
Number that met the criteria: 8 / 46
Area covered: Local
Source: Bhamra GJ (2015) Managing hyperglycaemia in acute coronary syndrome (ACS): Experience from a London hospital. Diabetic Medicine. Conference var.pagings


Recommendation: 1.1.3

Offer all patients with hyperglycaemia after ACS and without known diabetes tests for: HbA1c levels before discharge and fasting blood glucose levels no earlier than 4 days after the onset of ACS. These tests should not delay discharge.

What was measured: Proportion of people with hyperglycaemia after ACS and without known diabetes who had an HbA1c measured.
Data collection end: December 2012
0%
Number that met the criteria: / 4
Area covered: Local
Source: Bhamra GJ (2015) Managing hyperglycaemia in acute coronary syndrome (ACS): Experience from a London hospital. Diabetic Medicine. Conference var.pagings

What was measured: Proportion of people with hyperglycaemia after ACS and without known diabetes who had fasting blood glucose measured.
Data collection end: December 2012
25%
Number that met the criteria: 1 / 4
Area covered: Local
Source: Bhamra GJ (2015) Managing hyperglycaemia in acute coronary syndrome (ACS): Experience from a London hospital. Diabetic Medicine. Conference var.pagings



 Return to CG130 Overview